Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH AL 2018 | Overcoming the issues with clinical trial recruitment

Arnold Ganser • 4 May 2018
ESH AL 2018
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Leukemia Midostaurin
RATIFY

Arnold Ganser, MD, from the Hannover Medical School, Hannover, Germany, discusses the importance of collaborating with other trial groups that are focusing on acute leukemias by joining efforts with other experts at various networking events and conferences. Recorded at the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary.

Explore the AML Channel banner with headshots of Naval Daver, Eunice Wang, and Thomas Cluzeau

More from Arnold Ganser

Finding the right targets for CAR T-cell therapy in AML
1:41
Finding the right targets for CAR T-cell therapy in AML
Arnold Ganser • 4 May 2018
Midostaurin: the first drug to receive approval for AML since 2000
2:28
Midostaurin: the first drug to receive approval for AML since 2000
Arnold Ganser • 4 May 2018
The devastating effects of relapsed or refractory AML
3:00
The devastating effects of relapsed or refractory AML
Arnold Ganser • 4 May 2018
From bench to the bedside: understanding the genetic changes in AML
3:15
From bench to the bedside: understanding the genetic changes in AML
Arnold Ganser • 4 May 2018

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals